PER
Click for more information
2.41% 8.1¢ percheron therapeutics limited

Ann: Dosing Completed in ATL1103 Clinical Trial , page-2

  1. wormy
    2,405 Posts.
    clock Created with Sketch.
    11/10/11
    09:57
    Post #: 9123909
    re: Ann: Dosing Completed in ATL1103 Clinical...

    (.>_<)
    ANP Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.002(2.41%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.1¢ 8.2¢ 8.0¢ $39.27K 485.4K

Buyers (Bids)

No. Vol. Price($)
1 365000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 57142 1
View Market Depth
Last trade - 14.51pm 11/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.